Scandinavian ChemoTech AB logo

CMOTEC B - Scandinavian ChemoTech AB Share Price

SEK9.92 -0.0  -0.4%

Last Trade - 12:31pm

Sector
Healthcare
Size
Micro Cap
Market Cap £2.71m
Enterprise Value £2.59m
Revenue £48.5k
Position in Universe 1494th / 1562
Bullish
Bearish
Unlock CMOTEC B Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

CMOTEC B Revenue Unlock CMOTEC B Revenue

Net Income

CMOTEC B Net Income Unlock CMOTEC B Revenue

Normalised EPS

CMOTEC B Normalised EPS Unlock CMOTEC B Revenue

PE Ratio Range

CMOTEC B PE Ratio Range Unlock CMOTEC B Revenue

Dividend Yield Range

CMOTEC B Dividend Yield Range Unlock CMOTEC B Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CMOTEC B EPS Forecasts Unlock CMOTEC B Revenue
Profile Summary

Scandinavian ChemoTech AB is a Sweden-based company, which is primarily engaged in the healthcare industry. The Company is focused on cancer treatment and manufactures specialized medical equipment. The Company's product IQWave is an electrochemotherapy (ECT) device. The IQWave system enhances the effects of the chemotherapeutic substance by opening up small pores in the tumor cells, giving the injected chemotherapeutic substance (no more than 15 IU of bleomycin) direct access to the DNA of the target cells. Among the product's applications are hypernephroma, kaposi sarcoma, transitional cell carcinoma, head and neck squamous cell carcinoma, malignant melanoma, basal cell carcinoma. The treatment can be used for cutaneous as well as subcutaneous tumors.

Directors
Last Annual December 31st, 2018
Last Interim September 30th, 2019
Public Since December 6, 2016
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange OMX Nordic Exchange Stockholm
Shares in Issue 3,405,000
Free Float (0.0%)
Eligible for
ISAs
SIPPs
CMOTEC B Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CMOTEC B
Upcoming Events for CMOTEC B
Thursday 7th May, 2020 Estimate
Scandinavian ChemoTech AB Annual Shareholders Meeting
Similar to CMOTEC B
© Stockopedia 2019, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.